The phrase "abnormality management" is correct and usable in written English.
It can be used in contexts related to handling or addressing unusual situations, issues, or conditions, particularly in fields like healthcare, quality control, or project management.
Example: "The team implemented a new protocol for abnormality management to ensure that any deviations from the standard process were promptly addressed."
Alternatives: "issue management" or "anomaly handling".
BTX is clinically administrated to treat various therapeutic indications: strabismus, migraine, bladder dystonia, hyperhidrosis, cervical dystonia, upper limb spasticity, voice abnormality, chronic pain management, and cerebral palsy [6].
It might be expected that psychosocial effects may differ according to the severity of the smear abnormality, and the management strategy adopted.
The combination of specific CB and echocardiographic abnormalities has important management ramifications in regards to consideration of thrombolytic therapy for acute PE, even in the hemodynamically stable patient [62, 66].
Finally, the present analysis did not evaluate whether the absence of abnormalities influenced daily management in our ICU.
In siblings F4.1 and F4.2, electrolyte disturbance and endocrine abnormalities were major management problems (and may have contributed to the delay in the diagnosis of pyridoxine dependency).
The National Heart , Lung and Blood Institute Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents has specific lifestyle and pharmacotherapy recommendations for children with lipid abnormalities and specifies management for children with T1DM (125).
Currently, in the era of screening mammography, LCIS and ALH are not uncommonly identified as the most significant pathology in biopsies performed for breast abnormalities and their management remains controversial.
The combination of specific CB and echocardiographic abnormalities has important management ramifications in regards to consideration of thrombolytic therapy for acute PE, even in the hemodynamically stable patient [ 62, 66].
This leads to the suggestion that it is quite unlikely for the development of a single drug or even a combination of drugs targeting genetic abnormalities for the management or prevention of cancer.
